Monthly Archives: July 2020

COVID-19: FDA Emergency Use Authorization for a vaccine in the fall of 2020 means the time for public dialogue is August      

By on .

By Daniel R. Lucey M.D., MPH, FIDSA The only past U.S. Food and Drug Administration Emergency Use Authorization for any vaccine was in January 2005 for the licensed (since 1970) anthrax vaccine to be used in military personnel “for prevention of inhalation anthrax for individuals between 18 and 65 years of age who are deemed […]

First large-scale “real world” U.S. COVID-19 vaccine trial begins, with hopes for end-of-year results, mass distribution in 2021

By on .

Phase III trial launch reached with unprecedented speed, no compromises, NIH leaders say With a shot administered to a volunteer in Savannah, Georgia, late-stage testing of an experimental vaccine to protect against COVID-19 began this morning, with hopes for results that could see an effective preventive tool against the disease by the end of the […]

COVID-19: Mask policy appears to have controlled spread of virus at Missouri salon

By on .

With two stylists confirmed to have the virus, 139 customers as well as colleagues were tracked. None showed signs of infection. Adhering to local ordinance on masks can make a difference, CDC says . . . By the time a hair stylist in Springfield, Missouri received her test results showing she had COVID-19, she had […]

COVID-19: More than 90,000 infections, 500 deaths in U.S. health care personnel

By on .

By Daniel Lucey MD, MPH, FIDSA Today, more somber statistics on the pandemic posted on the U.S. Centers Disease Control COVID-19 website: Since the previous day, 54,357 new cases of SARS-CoV-2 infection were documented (of the total 2,679, 230 US cases in 2020, accordingly to the CDC). Not surprisingly, as the number of hospitalizations is […]